https://sms.carm.es/ricsmur/handle/123456789/17624 2026-11-15T09:32:14Z https://sms.carm.es/ricsmur/handle/123456789/29218 Análisis bibliométrico de la investigación española a lo largo de los cincuenta años del Calendario de vacunaciones e inmunizaciones a lo largo de la vida Pérez-Martín, Jaime-Jesús; Zornoza-Moreno, Matilde; Roca-Vega, Agustín FUNDAMENTOS // España celebra en 2025 los cincuenta años del Calendario de vacunaciones e inmunizaciones a lo largo de la vida, uno de los más completos a escala mundial. Sin embargo, existe poca evidencia de la evolución de la investigación en vacunas por autores de afiliación española durante este periodo. Por tanto, éste fue el objetivo principal del presente artículo. MÉTODOS // Se realizó un análisis bibliométrico descriptivo utilizando las principales bases de datos de acceso libre y especializadas en ciencias de la salud. Para la clasificación y el análisis de los distintos artículos se utilizaron distintas herramientas de inteligencia artificial. RESULTADOS // Desde el inicio del calendario de vacunación en España los artículos publicados supusieron el 2,23% del total de la investigación internacional, con un aumento desde el 0% en el quinquenio 1975-1979 al 3,12% en el 2020-2024. El número de ensayos clínicos publicados por autores españoles también fue en aumento, desde 4 en el quinquenio 1985-1989 a 363 entre los años 2020-2024 y 41 hasta el 13 de mayo de 2025. El mayor volumen de investigación se centró en el SARS-CoV-2 (21,97% del total). Los autores de origen español también pasaron de publicar un mayor volumen en su idioma (más del 30% del total hasta el quinquenio 2000-2004) a una internacionalización (más del 50% en los últimos años). CONCLUSIONES // La expansión internacional de la investigación española es evidente y exitosa en los últimos cincuenta años, con una tendencia creciente y un importante incremento en el quinquenio 2020-2024. 2026-06-16T00:00:00Z https://sms.carm.es/ricsmur/handle/123456789/29217 Digital mourning: Revisiting COVID-era #funeral discourse on Twitter Makita, Meiko; Caswell, Glenys; Mas-Bleda, Amalia The COVID-19 pandemic substantially disrupted funeral practices across the world, as public health restrictions limited gatherings and altered how funerals and mourning practices could take place. This study serves as a retrospective account of funeral-related discourse on Twitter, now X, during the first year of the pandemic. We conducted a mixed-methods content analysis of a random sample of 900 English-language posts containing the hashtag #funeral, drawn from a larger corpus of COVID-19-related tweets posted between February 2020 and January 2021. The analysis examined public expressions of grief, ritual disruption, adaptation, the role of funeral service professionals and related concerns during a period of widespread crisis. At the interpretive level, four overlapping discourses were identified across the thematic findings: disrupted rituals and mourning at a distance; visibility, unequal recognition and politicized mourning; funeral economies and unequal mourning; and professional care and ritual continuity under restriction. Rather than signaling a complete transformation of mourning, the findings show how established practices were publicly reconfigured through Twitter, altering how funeral-related experiences were made visible, circulated and contested during the pandemic. 2026-08-15T00:00:00Z https://sms.carm.es/ricsmur/handle/123456789/28824 Spanish adaptation of Beers criteria Pastor-Cano, Josep; Aranda-García, Ana; Rausell-Rausell, Víctor-José; Gascón-Cánovas, Juan-José; Tobaruela-Soto, Mariana BACKGROUND: The Beers criteria, which were drawn up in the USA and updated in 2012, were developed to detect potentially inappropriate prescriptions in older adults. Since there are significant differences between the Spanish and North American drug catalogues, our aim was to produce a Spanish adaptation of the criteria. PATIENTS AND METHODS: A comparison of the drugs mentioned in the Beers list with the 2012 Spanish Drugs Catalogue identified those active substances that were on the list in the USA but not commercially available in Spain. We also searched for Spanish drugs that were similar to those listed in the criteria. If these drugs were available in the USA, it was assumed that they had been evaluated by the Beers authors. On the other hand, if similar active substances were not available in the USA, they were evaluated by reference to three information sources: articles reviewed by the American Geriatrics Society in support of the Beers criteria, the product characteristics and information leaflets, and the European STOPP/START, NORGEP and PRISCUS criteria. RESULTS: Of the 199 active substances listed in the Beers criteria, 54 (27.0%) were not commercially available in Spain, but 50 new active substances could be included. These figures differed when "Direct Criteria" were considered: 47 (34.3%) active substances were not commercially available in Spain and 40 new ones could be included in the Beers list. As regards "Disease Dependent Criteria" the figures were 33 (21.3%) and 48, respectively. CONCLUSIONS: A great number of drugs on the Beers list were not commercially available in Spain, and we added many active substances not included in the original version. This study is thus an adaptation of the Beers Criteria to the Spanish health care scenario. 2015-12-01T00:00:00Z https://sms.carm.es/ricsmur/handle/123456789/28730 Balneotherapy in osteoarthritis Morer, Carla; Tenas, Dolors; López-Fernández, María-Antonia; Maraver, Francisco 2015-08-01T00:00:00Z